Synergen Technologies
Synergen Technologies's alternatives and competitors
See how Synergen Technologies compares to similar products. Synergen Technologies's top competitors include Intarcia Therapeutics, Axxia Pharmaceuticals, and Synthomer.
Intarcia Therapeutics operates as a biopharmaceutical company. The company develops and commercializes therapies to transform the prevention and management of chronic d…
View more in-depth data on:
- Competitors
- Products
- Customer References and more
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Axxia Pharmaceuticals is a specialty pharmaceutical company focused on implantable, polymeric drug delivery technologies. Axxia has a biocompatible, subcutaneous drug d…
Synergen Technologies vs. Axxia PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Synthomer (LSE: SYNT) operates as a specialty chemicals company. It develops, manufactures, and sells tackifying resins and additives for adhesive products. Its product…
Synergen Technologies vs. SynthomerView more in-depth data on:
- Competitors
- Products
- Customer References and more
Analyst Briefing SubmittedNeutroplast is a packaging production company for the pharmaceutical and personal care industries. It offers packaging services for pills, doses, beauty products, dropp…
Synergen Technologies vs. NeutroplastView more in-depth data on:
- Competitors
- Products
- Customer References and more
- OP
Opulus, Ltd. is a biotechnology company focused on the development of new measurement systems based on hyphenated Quartz Crystal Microbalance for molecular biology, dr…
Synergen Technologies vs. OpulusView more in-depth data on:
- Competitors
- Products
- Customer References and more
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Top 5 Synergen Technologies competitors
Compare Synergen Technologies to Competitors
Progression Therapeutics is a biotechnology company focused on the treatment of primary and metastatic cancer. The Company currently has multiple products in various stages of evaluation, including a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo.
Opal Therapeutics is an immunotherapy company focused on therapies for human immunodeficiency virus (HIV) and Hepatitis C (HCV), based on technology from the University of Melbourne.
NovaDigm Therapeutics is developing vaccines to protect patients from fungal and bacterial infections, which can be life-threatening and drug resistant. The company's lead product candidate, NDV-3, is a recombinant glycoprotein vaccine containing a candidal surface antigen, agglutinin-like sequence 3 protein or Als3. Results from a Phase 1 clinical trial demonstrated that a single dose of the NDV-3 vaccine was safe, well-tolerated and induced strong antibody and T-cell immune responses in healthy adults.
PDC Biotech is developing a compound, PDC31 which is being developed for the treatment of preterm labor and primary dysmenorrhea. PDC31 is a peptide antagonist of the prostaglandin F2a (FP) receptor, the lead in a series of FP antagonists exclusively licensed to PDC Biotech GmbH from Theratechnologies, (TSX: TH), a Canadian biopharmaceutical company.
Intercept Pharmaceuticals engages in the development and commercialization of novel therapeutics in the healthcare sector. Its offerings include the development and delivery of medicines for conditions such as primary biliary cholangitis and severe alcohol-associated hepatitis. The company primarily serves the healthcare industry, with a particular emphasis on liver health. It was founded in 2002 and is based in Morristown, New Jersey.
Cosmo is a fully-integrated speciality pharmaceutical company that aims to become engaged in the market of optimised therapies for selected gastro-intestinal diseases. The company's clinical development pipeline specifically addresses treatments for Inflammatory Bowel Diseases (IBD), such as Ulcerative Colitis and Crohn's Disease, as well as for colon infections.
Loading...